博济医药(300404.SZ)：目前公司海外业务占比较小

Core Viewpoint - The company, Boji Pharmaceutical (300404.SZ), is a specialized CRO service provider primarily offering outsourced pharmaceutical research and development services and charging technical service fees. Currently, the company's overseas business accounts for a small proportion of its overall operations [1]. Group 1 - The company focuses on providing CRO services to pharmaceutical enterprises [1] - The primary revenue model involves charging technical service fees for its services [1] - The company's international business presence is limited at this stage [1]